Meghmani Organics Limited has cleared the last real hurdle in folding two group companies into itself. The Ahmedabad Bench of the National Company Law Tribunal, comprising Judicial Member Shammi Khan and Technical Member Sanjeev Sharma, sanctioned the scheme of amalgamation of Kilburn Chemicals Limited and Meghmani Crop Nutrition Limited with Meghmani Organics on 8 October, bringing both transferor companies formally into the parent on an appointed date of 1 January 2026.
The scheme itself had already cleared the shareholder and creditor stage well before the tribunal's final order. Meetings convened on 6 June 2026 saw equity shareholders vote overwhelmingly in favour, with 99.99 per cent of the 10,67,12,427 votes cast backing the merger, while secured creditors approved it unanimously. The tribunal had directed those meetings back in April 2026, and by the time the matter returned for final sanction, there was no real shareholder or creditor opposition left for the bench to weigh.
What the tribunal did take care to spell out was what its sanction does not do. The order states plainly that approving the scheme is not to be read as granting any exemption from stamp duty, taxes, fees, cess or any other statutory levy that may be payable on the transaction. That caveat matters here because the Income Tax Department had flagged pending demands against both Kilburn Chemicals and Meghmani Organics during the proceedings, and it sought prior approval under Section 281 of the Income Tax Act before any transfer of capital assets under the scheme could go through. The tribunal's order leaves those claims intact rather than letting the merger wash them away.
On the company law side, the tribunal accepted the Official Liquidator's recommendation that Kilburn Chemicals and Meghmani Crop Nutrition be dissolved without being wound up, relying on Section 232(3)(d) of the Companies Act, which lets a tribunal order dissolution of a transferor company once its undertaking has vested in the transferee under an approved scheme. Both companies accepted that course, and with the tribunal's order, their separate corporate existence comes to an end. All their assets, liabilities, contracts, employees and pending proceedings transfer to Meghmani Organics with effect from the appointed date.
This sequence is a fairly ordinary one for a group-level consolidation, but the explicit tax caveat is the part worth remembering. Tribunals approving amalgamation schemes routinely carry language preserving statutory dues, yet it rarely gets tested in a live fact pattern with an actual pending demand on the table, as happened here with the Income Tax Department's Section 281 request. Promoters planning a similar group restructuring involving an entity with open tax assessments should expect the same treatment: the scheme will go through on its corporate merits, but the revenue authorities get to pursue their claims against the surviving entity exactly as they could have pursued them against the companies that no longer exist.
The broader point for transaction lawyers structuring intra-group mergers is timing. Kilburn Chemicals and Meghmani Crop Nutrition could not simply wait out their tax disputes and hope a merger would moot them; the tribunal's order makes clear that the successor company inherits those liabilities along with everything else. Due diligence on an amalgamating entity's outstanding tax position is not a formality to be ticked off before filing the scheme. It is a live question the tribunal itself will engage with if the tax department chooses to appear and object, as it did here.
None of this slowed the scheme down in any meaningful way. From the April 2026 order directing shareholder and creditor meetings to the final sanction on 8 October, the process ran its course over roughly six months, which is unremarkable for a group-level restructuring of this size involving three separate companies and multiple classes of stakeholders. The near-unanimous shareholder and creditor vote in June left the tribunal with little to adjudicate on the commercial merits of the scheme itself, so the Income Tax Department's intervention was really the only contested issue the bench had to resolve before granting sanction, and it resolved it by preserving the department's position rather than by delaying or denying the merger outright.
Promoters of similarly structured groups, where a listed parent absorbs smaller manufacturing or trading subsidiaries, can draw a fairly direct lesson from how this scheme played out. Getting shareholder and creditor approval early and comfortably, as Meghmani did with its June vote, does not insulate the scheme from scrutiny on unrelated statutory claims, and building the tax caveat into the scheme documents from the outset, rather than leaving it to be imposed by the tribunal at the sanction hearing, would likely save a round of argument the next time around.